{{Rsnum
|rsid=828054
|Chromosome=1
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=DPYD
|position=97144470
|Gene_s=DPYD,DPYD-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 28.3 | 49.6 | 22.1
| HCB | 97.1 | 2.9 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 82.3 | 16.3 | 1.4
| ASW | 50.9 | 45.6 | 3.5
| CHB | 97.1 | 2.9 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 69.3 | 27.7 | 3.0
| LWK | 67.0 | 30.3 | 2.8
| MEX | 37.9 | 50.0 | 12.1
| MKK | 49.4 | 41.7 | 9.0
| TSI | 30.4 | 44.1 | 25.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=25066213
|Title=Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}